P latelet adhesion to the subendothelium of an injured vessel wall and subsequent aggregation is a complex and critical event in platelet plug formation that requires the contribution of several adhesive proteins. One of these proteins is fibronectin (FN), which, together with von Willebrand factor (VWF) and fibrinogen, belongs to a group of major ligands thought to mediate platelet adhesion and aggregation.
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FN is a dimeric multidomain glycoprotein that exists in plasma and in tissue extracellular matrix. 1 The largest pool of soluble FN in the adult mammal is in plasma (plasma FN [pFN] ). pFN is produced specifically by hepatocytes and is present at 300 g/mL in human plasma and 580 g/mL in mice. 2 Cellular FN is found in an insoluble multimeric form in the extracellular matrix of many tissues. In platelets, both forms of FN are present: the soluble form taken up by platelets from plasma and the cellular form coming originally from megakaryocytes. However, platelets have no cell surface FN in their resting state. 3 FN performs a remarkably wide variety of activities: it plays a role in cell adhesion, migration, growth, and differentiation. FN is critically important in development, as demonstrated by early embryonic lethality in mice with targeted inactivation of the FNgene. 2 It is a ligand for many members of the integrin receptor family, and it can bind to a number of biologically important molecules, including fibrin, heparin, and collagen. 1 FN RNA is alternatively spliced at 3 regions: EIIIA(EDA), EIIIB(EDB), and V(CS-1). The alternatively spliced variants of FN containing the EIIIA and EIIIB splice variants are prominently expressed around developing blood vessels during embryonic growth. 4 In adults, EIIIA and EIIIB splice variants are downregulated but still mainly expressed in the walls of blood vessels. 5 EIIIA-null and EIIIB-null mice are viable and fertile, suggesting that embryonic vessel formation occurs normally in the absence of these splice variants. 6 -8 In normal plasma, most of the pFN lacks the EIIIA and EIIIB domains. However, both are present in plasma of patients with vascular injury or trauma 9 and in mice with chronic inflammation (apolipoprotein E-deficient mice). 8 Recently, our group reported that pFN is one of the ligands supporting platelet thrombus formation in vivo. In a model of arterial thrombosis, mice with complete deficiency of pFN (pFN conditional knockout mice) 10 had delayed thrombus formation and growth and subsequent occlusion of injured arterioles. 11 In this study, we asked whether a decrease in FN expression in the absence of interferon (IFN) would affect thrombus formation under arterial or venous flow conditions. This is important because reduced, but not absent, pFN is common in patients with liver disease and after trauma or surgery. We also wished to visualize pFN incorporation into the growing thrombi in vivo. Additionally, we were interested whether absence of EIIIA or EIIIB splice variants of cellular FN would affect thrombosis at high shear rate after acute vessel injury.
Methods

Mice
FNϩ/Ϫ, EIIIAϪ/Ϫ, EIIIBϪ/Ϫ (C57BL/6J background), and FN conditional knockout mice with corresponding control mice (FN flox / FN flox ;MxCreϩ and MxCreϪ) and their treatment with polyI-polyC were described previously. 2, 7, 8, 10 The heterozygous and corresponding wild-type (WT) mice were produced by heterozygous FNϩ/Ϫ and FNϩ/ϩ crosses. Age-matched control WT mice corresponding to EIIIAϪ/Ϫ and EIIIBϪ/Ϫ on C57BL/6J background were purchased from Jackson Laboratory (Bar Harbor, Me). The experimental procedures were performed at the CBR Institute for Biomedical Research and approved by its animal care and use committee.
Determination of Whole Blood Clotting Time
Whole blood clotting time was measured as described 12 with some modifications. Blood was collected into tubes containing 3.8% sodium citrate by cardiac puncture of the anesthetized mice. A total of 280 L of whole blood was added to 20 L of CaCl 2 in 37°C prewarmed cuvettes. The onset and clotting rate were measured by Sonoclot Coagulation and Platelet Function Analyzer (Sienco).
Bleeding Time Measurement
FNϩ/ϩ and FNϩ/Ϫ mice (9 to 10 weeks old) were anesthetized with ketamine/xylazine (150/15 mg/kg, IP), and a 3-mm segment of the tail was amputated. The tail was immersed in 0.9% isotonic saline at 37°C, and the time required for the stream of blood to stop was defined as the bleeding time.
Detection of FN
Platelets were isolated from pooled blood of 2 to 3 mice, and the same number of platelets was lysed for each genotype in 3 independent experiments. The plasma samples were obtained from single mice (3 per each group), and the same volumes were tested. Platelet and plasma samples were then analyzed by Western blot using a rabbit antibody against human FN with 1:3000 dilution (Sigma) followed by chemifluorescent detection (Amersham Biosciences) and quantified by using a PhosphorImager. pFN levels in FNϩ/ϩ, FNϩ/Ϫ, EIIIAϪ/Ϫ, and EIIIBϪ/Ϫ mice were additionally quantified by radial immunodiffusion using an antibody to human FN. 2 The levels of pFN in mice of C57BL/6J background were entirely comparable to those in mice on mixed background C57BL/6J/129sv. 2 
In Vivo Thrombosis Model
The arterial thrombosis model was described previously. 11, 13 Briefly, platelets from donor mice (Ͼ5 weeks old) were isolated from platelet-rich plasma and fluorescently labeled with calcein acetoxymethyl ester (Molecular Probes). The recipient mice (3 to 4 weeks old; weighing 12 to 15 g) were retro-orbitally injected with the fluorescently labeled platelets of matching genotype. A subgroup of FNϩ/Ϫ mice was then injected with rat pFN (Sigma; 290 g per mL of blood). Under anesthesia induced with intraperitoneal injection of tribromoethanol (Fluka; 0.15 mg/10 g of body weight), the mouse mesentery was then exteriorized through a midline abdominal incision. FeCl 3 (Sigma; 10 L of 250 mmol/L solution) was applied topically to an arteriole that induced local vessel injury and denudation of the endothelium. 13 For arterial thrombosis in EIIIAϪ/Ϫ, EIIIBϪ/Ϫ, and corresponding WT mice as well as for venous thrombosis, we used filter paper soaked in 10% FeCl 3 , which was placed for 5 minutes topically on the mesenteric vessels to induce the injury. Vessels were monitored for 40 minutes after injury or until full occlusion occurred (blood flow stopped for Ͼ30 s). If the vessel did not occlude, 40 minutes was taken as the occlusion time for data analysis.
In Vivo Detection of pFN in the Thrombus
Yellow green (excitation/emission; 505 nm/515 nm) and red (excitation/emission; 580 nm/605 nm) carboxylate-modified microspheres (1.0 m diameter; Molecular Probes) were covalently coupled to rat pFN (Sigma) and control rat IgG1 (BD Pharmingen), respectively. A total of 250 g protein in 0.5 mL 50 mmol/L 2-[N-Morpholino]ethane sulfonic acid buffer, pH 6.0, was coupled to 6.75ϫ10 9 microspheres according to manufacturer instructions (Molecular Probes). In the first experimental setting, WT C57BL/6 mice were infused with 2 sets of microspheres, pFN and control IgG, coated with different colors (0.5ϫ10 9 microspheres per mouse) 5 minutes after the vessel injury was induced by FeCl 3 . Mesenteric arterioles and venules were observed immediately thereafter by fluorescence intravital microscopy. In another experimental setting, the incorporation of pFN-coated microspheres (yellow green) specifically into thrombi was verified by using the calcein-labeled platelets (red-orange; Molecular Probes) injected into the same recipient mouse.
Statistical Analysis
Data are presented as meanϮSEM. Statistical significance was assessed by unpaired Student t test (for comparison of 2 groups) or by ANOVA with the Bonferroni test if Ͼ2 groups were compared. 
Results
Plasma and Platelet FN, Whole Blood Clotting, and Bleeding Time in FN؉/؊ Mice pFN is an important component of fibrin clots. 1 To evaluate whether a 55% reduction in pFN levels (determined by Western blot and confirmed by radial diffusion assay) and a 21% reduction in platelet FN content as determined by Western blot (Figure 1 ) in FNϩ/Ϫ mice affect hemostatic parameters, we measured the whole blood clotting time, clot rate, and bleeding time. The onset and the clotting rate of whole blood in vitro were not significantly different in FNϩ/Ϫ mice compared with control mice. Additionally, both groups of mice were able to control their blood loss without cauterization after amputation of a 3-mm portion of the tail. Thus, the bleeding time and clot formation were not significantly impaired in FNϩ/Ϫ mice (Table) .
Early Platelet Adhesion and Thrombus Formation in Arterioles of FN؉/؊ Mice
To evaluate whether a decreased level of pFN affects platelet adhesion and thrombus formation in arterioles, we superfused ferric chloride on the vessel and observed the behavior of fluorescent platelets by intravital microscopy. The numbers of single platelets, adhering during the interval 2 to 3 minutes after the vessel injury, were not significantly different in FNϩ/Ϫ compared with FNϩ/ϩ mice (38Ϯ7 in FNϩ/Ϫ versus 52Ϯ9 in FNϩ/ϩ; PϾ0.05). On the other hand, we found a striking delay of several minutes in appearance of the first thrombus in the injured arterioles in FNϩ/Ϫ mice when compared with FNϩ/ϩ (14.4Ϯ1.04 minutes in FNϩ/Ϫ versus 5.7Ϯ1.02 minutes in FNϩ/ϩ; PϽ0.001). We observed that the thrombi grew very slowly in the FNϩ/Ϫ, although they were stably anchored to the vessel wall. The growth of the thrombus was slowed down by constant platelet shedding (Figure 2 ).
Occlusion of Arterioles and Thrombus Embolization in FN؉/؊ Mice
The lack of firm adhesion of the platelets to the thrombus led to occlusion delay in FNϩ/Ϫ mice (36.8Ϯ2.7 minutes in FNϩ/Ϫ versus 28Ϯ1.6 minutes in FNϩ/ϩ; PϽ0.01). The difference in occlusion time is an underestimate because the majority of arterioles in the FNϩ/Ϫ mice were not occluded by the 40 minutes observation period. In contrast, all FNϩ/ϩ mice occluded before this time point ( Figure 3A) . Despite the constant shedding of single platelets or small platelet clumps in FNϩ/Ϫ mice, the thrombi did not produce many large emboli of diameter Ͼ30 m. Thus, the frequency of large emboli in FNϩ/Ϫ mice was not different from FNϩ/ϩ mice (2.25Ϯ0.62 in FNϩ/Ϫ versus 2.6Ϯ0.6 in FNϩ/ϩ; PϾ0.05).
Infusion of Rat pFN in FN؉/؊ Mice Resulted in Normal Thrombus Growth
To determine whether it was the decrease in plasma or cellular FN that was responsible for the thrombotic defect in FNϩ/Ϫ mice, we reconstituted the pFN to WT levels by infusion of rat pFN. The level of pFN in FNϩ/Ϫ mice was determined before infusion and after infusion/intravital microscopy in the same mice by Western blot ( Figure 1A ). The normalization of pFN level in FNϩ/Ϫ mice prevented platelet shedding from thrombi and produced occlusion of injured arterioles in all animals ( Figure 2 , bottom panels; Figure 3A ).
Thrombogenesis in Venules of FN؉/؊ Mice
Because the injured arterioles of FNϩ/Ϫ mice had such a striking thrombosis phenotype, we were interested to assess the venous thrombogenesis as well and have developed a venous thrombosis model for this purpose. We investigated the thrombus growth by observing FeCl 3 -injured venules of 200 to 300 m in diameter. The growth of thrombi at low venular shear rate was not affected in FNϩ/Ϫ mice with venules occluding at similar time points compared with control mice (22Ϯ4 minutes in FNϩ/Ϫ versus 20Ϯ2 minutes in FNϩ/ϩ; PϾ0.05; Figure 3B ). Because this was not shown previously, we also studied the venous thrombosis in FN 
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conditional knockout mice. 10 
In Vivo Incorporation of FN Into Thrombus
To visualize incorporation of FN into the growing thrombi in the injured vessels, we injected WT mice with pFN coupled to fluorescent microspheres (1 m diameter) together with microspheres of a different color coupled to a control protein (IgG). The injected pFN microspheres were seen binding to thrombi growing in both mesenteric arterioles and venules as well as to injured vessel wall with denuded endothelium ( Figure 4A ). Control protein (IgG) coupled to microspheres did not bind to the thrombi nor to injured vessel wall ( Figure  4B ). In another study, we showed that fluorescently labeled platelets codistributed with the pFN microspheres incorporated into thrombi ( Figure 4C and 4D).
Thrombosis in Arterioles of Mice Lacking the Alternatively Spliced EIIIA or EIIIB Domains of FN
We investigated the effect of absence of cellular FN splice domains on thrombosis using EIIIAϪ/Ϫ and EIIIBϪ/Ϫ mice. The absence of either splice domain of FN did not affect plasma levels of FN, as determined by Western blot ( Figure  5A ) and by radial immunodiffusion (data not shown). Figure 5B ). Thus, the alternatively spliced EIIIA and EIIIB domains, present in cellular and platelet FN, do not play an important role in thrombus formation.
Discussion
The studies presented here underscore the importance of pFN in the process of arterial thrombus formation. In the FeCl 3 -induced thrombosis model, we observed significantly delayed thrombus formation in arterioles after vessel wall injury despite normal platelet tethering in FNϩ/Ϫ mice compared with FNϩ/ϩ mice. Furthermore, we noted constant shedding of platelets from the growing thrombi, which eventually led to occlusion delay, with the majority of arterioles in FNϩ/Ϫ mice remaining patent. The occlusion defect was successfully rescued in FNϩ/Ϫ by infusion of rat pFN in FNϩ/Ϫ that normalized the pFN levels. The defect in thrombosis in the FNϩ/Ϫ mice strikingly resembles the phenotype observed in vivo by intravital microscopy in mice with an induced complete deficiency of pFN (pFN conditional knockout mice). 11 However, the FNϩ/Ϫ mouse offers several advantages over the pFN conditional knockout model for studies of the role of FN in thrombosis. First, the FNϩ/Ϫ mouse model reflects a more physiological decrease of pFN. Indeed, the reduced plasma level, but not complete deficiency of FN, is common in several disease states. 14 Patients with liver disease, renal failure, sepsis, and after trauma or surgery have been found to exhibit low concentrations of pFN, which may contribute to the hemostatic defects so often seen in these patients. [15] [16] [17] Second, we did not have to induce IFN production by treatment with polyI-polyC (IFN inducer used in FN conditional knockout mice) to excise the FN gene. This is important because both polyI-polyC and IFN could affect platelet function. 18 This all makes the FN heterozygous mouse model attractive for studying the role of FN function in vivo.
Using a FeCl 3 -induced vessel wall injury model, we examined the pFN incorporation into the growing thrombi in WT mice. Fluorescently labeled pFN microspheres infused into a mouse specifically localized within the developing thrombi in arterioles and venules, indicating that pFN becomes an integral part of the thrombus at both high and low shear rate conditions. Several known interactions of pFN, for example with fibrin, collagen, and activated platelets, could be of importance in thrombus formation after injury. During coagulation, soluble FN is cross-linked to fibrin molecules by Factor XIIIa transglutaminase, which enhances the stability of the clot. 19 Furthermore, incorporation of FN into fibrin augments the growth of thrombi in vitro. 20 We observed no difference in clotting in FNϩ/Ϫ mice compared with WT mice. Our results indicate that the polymerization and gelation of fibrinogen is not affected by the partial reduction in FN levels. This is in line with the results of in vitro plasma clotting activity measurement in pFN conditional knockout mice. 10 Furthermore, the case of a family with low pFN levels has been reported with no abnormal hematologic laboratory tests. 21 Activated platelets have the ability to bind exogenous pFN through integrins ␣IIb␤3 or ␣5␤1 expressed on their surface. This happens in Arg-Gly-Asp (RGD) sequence-dependent and -independent manners. 22, 23 The platelet membrane receptor ␣IIb␤3, which is a key integrin in thrombus formation, is known to bind fibrinogen and VWF in addition to pFN and to promote the internalization of fibrinogen 24 and FN into ␣-granules of platelets. 13 Recently, it was demonstrated that FN can engage ␣IIb␤3 in a similar manner to fibrinogen. The engagement is associated with an activation of signaling events, including tyrosine phosphorylation of focal adhesion kinase and phospholipase C␥2 with intracellular mobilization of calcium. 25 This outside-in signaling induced by FN through ␣IIb␤3 might be ultimately necessary for full platelet spreading, aggregation, and effective hemostatic plug formation. In vivo, this optimal outside-in signaling by FN might help to glue the platelets to each other during thrombus formation at high shear rates, a process most defective in mice with reduced pFN.
In vitro experiments suggested that pFN stimulates the binding of platelets to collagen 3, 26 and to subendothelium both under arterial and venous flow conditions. 27 Additionally, the cellular FN normally present in subendothelium can, during vessel injury, contribute to platelet adhesion as shown in vitro. 28 In the FeCl 3 -induced injury model, we did not observe a significant decrease of early platelet interaction with subendothelium in FNϩ/Ϫ compared with FNϩ/ϩ mice, indicating that significant reduction in pFN and also cellular FN do not affect this process. In the arterial system, in which the interaction of vWF with GPIb is of critical importance, pFN or cellular FN likely plays only a secondary role in the initial platelet adhesion.
In our model, thrombogenesis at low shear rate was not influenced by a decrease of FN in plasma. The role of FN in thrombosis appears shear dependent, with a prominent role at arterial shear rate. This is very similar to the thrombosis phenotype seen in vessels of CD40LϪ/Ϫ mice, which present thrombus instability specifically at arterial shear rate. 29 Interestingly, the CD40LϪ/Ϫ mice, like FNϩ/Ϫ mice, exhibit normal bleeding time. 29 CD40L is known to stabilize arterial thrombi by a ␤3 integrin-dependent signaling, 29 and this could also be the case for FN.
Although the decrease of pFN in FNϩ/Ϫ mice (as described in this study) and pFN deficiency 10 are associated with impaired arterial thrombosis, elevation of pFN may have the opposite effect. 20 High levels of pFN have been found in both patients and experimental animals with thrombotic acute coronary syndromes. 30, 31 Thus, information about pFN levels might provide insights as to the probability of arterial thrombotic events. Our results suggest that the thrombosis defect in FNϩ/Ϫ mice was attributable to a decrease in pFN and not cellular FN. This conclusion is based on 2 observations: first, the restoration of pFN up to WT level corrected the thrombosis defect in FNϩ/Ϫ mice, and second, absence of splice domains specific to cellular FN, EIIIA, or EIIIB did not affect thrombosis.
In acute vascular injury, EIIIAϩ and EIIIBϩ isoforms of FN are released into the circulation where they are normally not present. 9 Therefore, they are recognized as markers of acute vascular tissue injury, but their function is not clear. In the FeCl 3 injury model, as mentioned above, the thrombus growth and occlusion at high shear rate were not influenced by the absence of either the EIIIA or EIIIB isoforms of FN.
In conclusion, we describe haploid insufficiency for FN, and the observed defect in the FN heterozygous mice further demonstrates the primary importance of this adhesion molecule in arterial thrombosis. In addition, our studies suggest that defective platelet function could be present in patients with reduced pFN levels. 
